文献速递糖尿病

可穿戴设备量化偶然性体力活动与2型糖尿病的剂量反应关系:一项前瞻性队列研究

The dose-response association between wearables-quantified incidental physical activity and type 2 diabetes: a prospective cohort study.
PubMed 文献 · J Clin Endocrinol Metab · 2026-09-24

结果显示中强度和高强度偶然性体力活动与2型糖尿病风险呈近线性负相关,而低强度活动无一致剂量反应关系。1分钟高强度活动相当于5.9分钟中强度或46.6分钟低强度活动的风险降低效果。

要点

  • 中强度和高强度偶然性体力活动与2型糖尿病风险呈剂量依赖性降低。
  • 每日4.75分钟高强度活动对应HR 0.62,23.70分钟中强度活动对应HR 0.67。
  • 1分钟高强度活动相当于5.9分钟中强度或46.6分钟低强度活动的风险降低效果。

核心结论

  • 中强度和高强度偶然性体力活动与2型糖尿病风险降低呈剂量依赖性关联。
  • 低强度偶然性体力活动虽与风险降低相关,但无一致剂量反应关系。

研究设计与样本

  • 排除基线2型糖尿病、使用胰岛素治疗或随访12个月内诊断2型糖尿病者。
  • 通过设备测量偶然性体力活动,分为低强度(1.5至<3 METs)、中强度(3至<6 METs)和高强度(≥6 METs)。
  • 主要分析随访7.8年,2型糖尿病状态主要来自初级保健记录。

主要发现

  • 随访期间721名(3.2%)参与者发生2型糖尿病。
  • 中强度和高强度偶然性体力活动与2型糖尿病风险呈近线性负相关,低强度无一致剂量反应关系。
  • 每日高强度活动中位数4.75分钟对应HR 0.62(95%CI 0.53-0.73)。
  • 每日中强度活动中位数23.70分钟对应HR 0.67(95%CI 0.52-0.86)。
  • 每日1分钟高强度活动相当于5.9分钟中强度活动或46.6分钟低强度活动的2型糖尿病风险降低效果。

临床怎么用

  • 在不锻炼的成年人中,鼓励增加中强度和高强度偶然性体力活动可能有助于降低2型糖尿病风险。
  • 高强度偶然性体力活动在相同时间内可能带来更大的2型糖尿病风险降低效益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: This prospective cohort study aimed to quantify dose-response associations between intensity-specific incidental physical activity (IPA) and the incidence of type 2 diabetes (T2D) in a large cohort of UK adults. A secondary aim was to estimate the T2D-specific equivalence of 1 minute of vigorous-intensity IPA relative to moderate- and light-intensity IPA. METHODS: Participants were adults from the UK Biobank accelerometry sub-study who self-reported as nonexercisers. Individuals were excluded if they had T2D at baseline, were using insulin therapy, or received a T2D diagnosis within 12 months of follow-up. T2D status was primarily derived from primary care records. Device-measured IPA was categorized into light (LIPA; 1.5 to <3 METs), moderate (MIPA; 3 to <6 METs), and vigorous (VIPA; ≥6 METs) intensities. Additional analyses examined the T2D-specific equivalence of 1 minute of VIPA to MIPA and LIPA. The reference group comprised participants accumulating neither MIPA nor VIPA. RESULTS: The primary analysis included 22 857 nonexercisers (mean age 62.1 ± 7.7 years, 42.8% male). Over a 7.8-year follow-up period, 721 (3.2%) participants developed T2D. MIPA and VIPA, but not LIPA, exhibited near-linear inverse associations with T2D risk. Median VIPA (4.75 minutes/day) was associated with a hazard ratio (HR) 0.62 [95% confidence interval (CI) 0.53-0.73], and median MIPA (23.70 minutes/day) showed a HR of 0.67 (95% CI: 0.52-0.86). One minute of VIPA/day was associated with an equivalent T2D risk reduction of 5.9 minutes MIPA/day and 46.6 minutes LIPA/day. CONCLUSION: MIPA and VIPA were associated with lower T2D risk in a dose-dependent manner. Although median LIPA was linked to reduced risk, it did not demonstrate a consistent dose-response relationship.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Sabag A, Biswas RK, Koemel NA, et al. The dose-response association between wearables-quantified incidental physical activity and type 2 diabetes: a prospective cohort study. J Clin Endocrinol Metab. 2026. PMID: 42784530. doi:10.1210/clinem/dgag316

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。